Biolase (BIOL) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BIOLASE Reports 2018 First Quarter Results
May 2, 2018 4:05 PM EDTIRVINE, Calif., May 2, 2018 /PRNewswire/ --Â BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for its first quarter ended March 31, 2018.
Net revenue for the first quarter of 2018 was $10.0 million, an 8% decrease from the first quarter of 2017; however, BIOLASE continued to make progress in several key areas. The Company continued its strategy of increasing its focus on obtaining new customers, which resulted in new customers in direct markets buying more than 60% of the all-tissue laser systems sold during the first quarter of 2018.... More



